Pharvaris NV at Bank of America Healthcare Conference Transcript
(audio in progress) everybody, good morning. Welcome to the Bank of America Healthcare Conference. I am Tazeen Ahmad, I am one of the senior SMID biotech analysts here at the bank. It is my pleasure to have our next presenting company with us, Pharvaris. Sitting up here with me are team members from the management team. We've got Chief Executive Officer, Berndt Modig; as well as Morgan Conn who is Chief Business Officer.
Questions & Answers
So let's start off, maybe, Berndt, if you could give us a couple of minute overview of the company, your platform, your areas of focus, and then we can go into a little bit more detailed Q&A if that works.
Sure, yeah. Absolutely. So yeah. Thanks and good to be here today. And thanks for coming to listen to our story about Pharvaris. Pharvaris is a clinical-stage company, and we are working on improving therapies and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |


